Table 3.
ID | Bleeding Classification | Bleeding Time (Days) | Time of DAPT Discontinuation (Days) | Adverse Events | Events Time (Days) |
---|---|---|---|---|---|
3 | Major/minor (GI bleeding) | 196 | 197 | TLR | 307 |
348 | Major/minor (GI bleeding) | 219 | 219 | Sudden death/ST | 312 |
923 | Minimal (Gum bleeding) | 222 | 223 | TLR | 351 |
975 | Major/minor (GI bleeding) | 239 | 239 | Died of HF | 351 |
1,276 | Major/minor (GI bleeding) | 263 | 263 | Died of VA | 329 |
1,461 | Major/minor (ICH) | 247 | 247 | Died of ICH | 247 |
1,749 | Major/minor (GI bleeding) | 206 | 206 | Sudden death/ST | 227 |
1,780 | Major/minor (GI bleeding) | 224 | 225 | MI | 291 |
2,056 | Minimal (Gum bleeding) | 236 | 236 | TLR | 299 |
DAPT, dual antiplatelet therapy; TLR, target lesion revascularization; ST stent thrombosis; VA, ventricular arrhythmias; ICH, intracerebral hemorrhage; MI, myocardial infarction.